@the_news_21
Indian government earlier said that they will bring foreign vaccines in the country. Even though, vaccine companies like Pfizer and Moderna for example remain hesitant to apply even as reports indicate that the Johnson and Johnson vaccine will be imported to India by June or July 2021.
On Monday, Pfizer CEO Albert Bourla said said that the company is in discussions with the Indian government seeking an “expedited approval pathway” for its COVID-19 vaccine. “Unfortunately, our vaccine is not registered in India although our application was submitted months ago,” he wrote in a LinkedIn post.
A company spokesperson told Reuters on Monday that Pfizer had sought an exception to even the current trial rules. “Pfizer’s application for emergency use authorization was supported with data that shows an overall efficacy rate of 95% with no safety concerns,” the official reminded.
